Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 982 results for "hepatitis"

Envisionrx And Gilead Sciences, Inc. Sign Exclusive Agreement ...

TWINSBURG, Ohio--( BUSINESS WIRE )--EnvisionRx®, a national, full-service pharmacy benefit management (PBM) company, today announced a partnership with Gilead Sciences Inc., a pioneer in the treatment of the Hepatitis C virus (HCV), ... BioSpace, 1 hour ago

1,714 images for hepatitis

Pharma Letter, 10 hours ago
Fox Toledo, 4 days ago
InterpressNews, 1 week ago
Houston Chronicle, 5 days ago
Drug Discovery and Development, 5 hours ago
Chicago Daily Herald, 1 week ago
570News, 6 hours ago
Med India, 1 week ago
Down to Earth, 1 week ago
Mother Jones, 3 hours ago

Gilead Sciences, Inc. (NASDAQ:GILD) Will Allow Generic Drugs Manufacturers To Make New Version Of Sovaldi

Gilead Sciences, Inc. ( NASDAQ:GILD ) is planning to launch its blockbuster hepatitis C drug Sovaldi in India by June this year, the company announced before US markets opened for trading Monday.The biotech firm also said that it aims to further the ...
 Bidness Etc7 hours ago German Insurers Get Gilead Sciences, Inc.'s (GILD) Sovaldi At Discounted Prices  Bidness Etc11 hours ago Gilead cuts hepatitis C drug prices in Germany  National AIDS Treatment Advocacy Project2 hours ago Gilead Making Progress on Generic Sovaldi in India  American Journal of Managed Care6 hours ago

PBM EnvisionRx chooses Gilead hepatitis C drugs for its formulary

Jan 26 (Reuters) - Pharmacy benefits manager EnvisionRx said on Monday it reached an agreement to provide its customers with Gilead Sciences Inc's hepatitis C drugs on an exclusive basis, the latest Gilead victory in a market share battle with ...
 Reuters3 hours ago

Gilead expands hepatitis C licensing pacts with Indian firms

g firm Gilead Sciences Inc has expanded its hepatitis C generic licensing agreements with India-based firms to include investigational pan-genotypic medicine GS-5816 as part of a single tablet regimen that combines it and sofosbuvir. The investigational NS5A ...
 Business Standard11 hours ago Gilead expands hepatitis-C licensing pacts  Business Standard1 hour ago Gilead expands generic drug deals to include NS5A inhibitor GS-5816  FirstWord Pharma10 hours ago

Hepatitis B Foundation Welcomes Two New Board Members

Pharmaceutical industry executive Wayne Yetter and engineering industry executive Craig Esterly to serve on board of national nonprofit research and disease advocacy organization The Hepatitis B Foundation ( is pleased to ...
 PRWeb15 hours ago

Hepatitis C Infection Screening Could Save Lives

Chronic hepatitis C (HCV) infection is difficult to detect during routine medical visits because there are usually no symptoms and it is often diagnosed in the advanced stages of the disease, making treatment difficult and often resulting in death. ...
 Lab Medica16 hours ago

263 hepatitis patients provided free treatment

ISLAMABAD (APP): Federal Government Polyclinic Complex (FGPC), providing free of cost treatment to Hepatitis patients, has provided treatment to 35 patents of Hepatitis-B and 228 patients of Hepatitis-C during last year. Besides, Pakistan Institute ...
 Frontier Post16 hours ago

Current and Future HCV Therapy

Abstract and Introduction Abstract Eradication of hepatitis C virus (HCV) infection, at least in compensated patients, can help improve the outcomes of liver disease such as cirrhosis, hepatocellular carcinoma (HCC) and liver transplantation, as ...
 Diabetes Care17 hours ago Hepatitis C Virus Infection Associated with Rheumatoid Arthritis  The-Rheumatologist.org2 days ago

Gilead discounts hep C meds in Germany, offers new-and-improved generics deal in India

Gilead Sciences ($GILD) has been negotiating all over the place. The U.S.-based drugmaker reportedly inked its first hepatitis C discount deals in Germany, and it's announcing a new offer to bring a Sovaldi follow-up to India even before it's ...
 FiercePharma6 hours ago German insurers win discounts on Gilead's Sovaldi  Yahoo! UK and Ireland2 days ago
Pharma Letter

Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent

 A.M. Best7 hours ago Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen26-01-2015  Pharma Letter9 hours ago Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent  A.M. Best17 hours ago Mylan Inc. Expands Hepatitis C Licensing Agreement With Gilead Sciences, Inc. To Include Investigational Pan-Genotypic Agent  BioSpace4 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less